Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that th
A drug designed to cut off a tumor's blood supply, when paired with a chemotherapy combination, resulted in significant improvement in survival in patients with metastatic colorectal cancer, the first time in decades that survival times have been extended
Solvay has re-evaluated the commercial potential of bifeprunox, a Solvay compound in clinical development for the treatment of schizophrenia . Bifeprunox additionally has the potential to be developed in other disorders, i.e.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA? (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom
The days of 'one size fits all' medicines may soon be a thing of the past for people undergoing radical drug therapies for chronic or serious illnesses. Chemotherapy with few side effects is just one of the possible breakthroughs in what is a ne
The Pharmacy Care Alliance (PCA) today announced that AstraZeneca, Johnson & Johnson Pharmaceutical Companies, Inc., Eli Lilly and Company, Merck and Novartis will make many prescription drugs available to qualifying PCA Medicare discount cardholder
Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).
Participants at the Susan G. Komen Breast Cancer Foundation National Race for the Cure? were among the first to view a new breast cancer ribbon today as they descended on the National Mall. More than 51,000 runners and walkers, more than including 3,500
Amylin Pharmaceuticals, Inc., and Eli Lilly and Company have presented detailed 30-week data from two of the three pivotal Phase 3 studies of exenatide during a late-breaking session
Clinicians from the McGill University Health Centre and the Centre hospitalier de l'Université de Montréal (CHUM) are participating in the first Canadian therapeutic HIV vaccine trial. Funded by a number of public and private institutions,
"The rising cost of prescription drugs is a major concern to all Michigan consumers, insured and uninsured, young and old. Michigan families, especially senior citizens, are hit hard each month?digging deeper into their fixed incomes in order to pay for life-saving medications," Cox stated. "Providing consumers with a user-friendly website will empower consumers to purchase their prescription drugs at the lowest cost. I hope to work with state agencies to pass that information on to consumers so they can make good choices about where to fill their prescriptions." Cox said.
Cox requested Michigan's Department of Community Health (MDCH) to provide Michigan consumers with prescription drug pricing information on a user-friendly, drug cost website. As the administrator of the State's Medicaid program, MDCH regularly obtains usual and customary drug pricing information that is reported by every Michigan pharmacy that fills Medicaid prescriptions. This pricing information is provided to MDCH by First Health Services Corporation, a Virginia company, which provides pharmacy benefits management services to the State's Medicaid program. Several months ago, Attorney General Cox requested First Health Services Corporation to provide usual and customary pricing information directly to the Attorney General's office, so that the Attorney General could pass on pricing information to Michigan consumers. First Health Services declined the request, stating it could only provide pricing information to MDCH, since that Department holds the Medicaid contract with First Health.
Cox notes that there are other state Attorneys General who currently provide drug pricing information to consumers. The Maryland Attorney General posts drug prices for the top 25 drugs prescribed in their state. First Health Services supplies drug pricing information to the Maryland Department of Attorney General and J. Joseph Curran Jr. First Health Services is also the pharmacy benefits manager for the State of Maryland's Medicaid program. Attorney General Curran worked cooperatively with the assistance of the State's Department of Mental Hygiene, which administers the Maryland Medicaid program to provide drug pricing information to Maryland consumers.
"A good way to get the best price for prescription drugs is to provide consumers with the information where they can get the cheapest prescription drugs. Information is power and my hope is that with this website Michigan consumers are empowered to get prescription drugs at the lowest price possible," Cox said.
http://www.michigan.gov/